ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Unveiling the Research Landscape and Emerging Trends in Cell Cycle for Cancer Immunotherapy: A Bibliometric Analysis (1990-2022)

Feng, Cheng; Li, Yuan; Zang, Mengya; Jin-si-han, E-er-man-bie-ke; He, Meng*; Lu, Zhenhai*南方医科大学; 中国医学科学院; 中山大学; 中国医学科学院北京协和医院
MEDICAL SCIENCE MONITOR2023-12-1DOI: 10.12659/MSM.940556
2阅读
引用收藏
分享

摘要

Background: The direct and indirect roles of the cell cycle in immunology of the tumor microenvironment (TME) are topics of intense scientific interest. Therefore, this study aimed to investigate the knowledge domain and hotspots related to the cell cycle for cancer immunology applications. Material/Methods: The Web of Science Core Collection (WoSCC) was used as a powerful tool for identifying articles related to cell cycle for cancer immunology applications. Co-occurrence relationships were examined with R, VOSviewer, and CiteSpace software. Related research hotspots and possible future trends were also examined. Results: A total of 1844 qualified English-language documents were obtained in WoSCC between 1999 and 2022, with a 7.66% annual growth rate. These eligible studies were co-authored by 2246 institutions in 51 countries/regions, with the greatest article number being published in the United States (36%, 664/1844), followed by China (19%, 351/1844) and Germany (4.5%, 83/1844). The top 3 institutions with the most publications and the top 3 academic journals (n=390 in total) on this topic that published the most articles were identified. Key nodes from the co-cited network were aggregated and identified to reveal the shift in cell cycle for cancer immunology applications. Notably, the current research hotspots in this field include "tumor progression", "chemotherapy", "resistance", "clinical trial", and "target population". Conclusions: This study revealed field profiles, research hotspots, and future directions of cell cycle dysregulation-related immunology, and the findings will offer a vigorous roadmap for further studies in the combination therapy of cell cycle inhibitors and immune checkpoint inhibitors for treating various cancers. Our results can shed more light on relevant research in this field.

学科与关键词

关键词
Cell CycleTumor MicroenvironmentImmunotherapyNeoplasms
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
MEDICAL SCIENCE MONITOR
发表日期
2023-12-01
卷期
第 29 卷
页码
e940556
DOI
10.12659/MSM.940556
成果收录
SCIE

作者

  • F

    Feng, Cheng (第一作者)

  • L

    Li, Yuan

    southern med univ · sun yat sen univ

查看全部 6 位作者收起作者
  • Z

    Zang, Mengya

  • J

    Jin-si-han, E-er-man-bie-ke

    sun yat sen univ

  • H

    He, Meng (通讯)

    chinese acad med sci · peking union med coll

  • L

    Lu, Zhenhai (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417